Affordable Access

Evaluation of eplerenone in the subgroup of EPHESUS patients with baseline left ventricular ejection fraction <or=30%.

Authors
Type
Published Article
Journal
European journal of heart failure
Publication Date
Volume
8
Issue
3
Pages
295–301
Identifiers
PMID: 16504579
Source
Medline

Abstract

Treatment with eplerenone plus standard therapy in patients with post-AMI HF and LVEF <or=30% provided significant incremental benefits in reducing both early and late mortality and morbidity.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments